Clozapine-induced systemic lupus erythematosus

Annals of Pharmacotherapy

Volumn 40, Issue 5, 2006, Pages 983-985

  Rami, Abu Fanne ^a   Barkan, Daniel ^a   Mevorach, Dror ^a   Leitersdorf, Eran ^a,b   Caraco, Yoseph ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Hadassah University Hospital ^*  (Israel)

Author keywords

Clozapine; Drug induced lupus; Hypersensitivity reaction; Schizophrenia

Indexed keywords

ANTINUCLEAR ANTIBODY; CLOZAPINE; COMPLEMENT COMPONENT C3; DNA ANTIBODY; HISTONE ANTIBODY; NAPROXEN;

ADULT; ANTIBODY DETECTION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE MARKER; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LUPUS LIKE SYNDROME; MUSCLE BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SCHIZOPHRENIA;

EID: 33646792903     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G552     Document Type: Article

References (14)

1. Hunziker F, Lauener H, Schmutz J. [1,4]-diazepine derivatives with basic substitutions in position 10. 1. on 7-membered heterocylic compounds. Arzneimittelforschung 1963;13:324-8.
2. Hippius H. The history of clozapine. Psychopharmacology 1989;99(suppl):S3-5.
3. Young CR, Bowers MB Jr, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull 1998;24:381-90.
4. Wolf J, Sartorius A, Alm B, Henn FA. Clozapine-induced lupus erythematosus. J Clin Psychopharmacol 2004;24:236-8.
5. Wickert WA, Campbell NR, Martin L. Acute severe adverse clozapine reaction resembling SLE. Postgrad Med J 1994;70:940-1.
6. Antonov D, Kazandjieva J, Etugov D, Gospodinov D, Tsankov N. Drug-induced lupus erythematosus. Clin Dermatol 2004;22:157-66.
7. Richelson E, Elson A. Antagonism of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 1984;103:197-214.
8. Baldessarini RJ, Frankenburg FR. Clozapine-a novel antipsychotic agent. N Engl J Med 1991;324:746-54.
9. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
10. Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 1999;46:73-7.
11. Baumgartner C, Bucher U. [Sea-blue histiocytes and Gaucher-like cells. Occurrence and significance.] German. Blut 1975;30:309-24.
12. Rubin RL. Drug-induced lupus. Toxicology 2005;290:135-47.
13. Uetrecht J. Current trends in drug-induced autoimmunity. Autoimmun Rev 2005;4:309-14.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.